KAM
RPRX

Kassirer Asset Management’s Repros Therapeutics Inc. RPRX Stock Holding History

Kassirer Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-659,230
Closed -$435K – 105
2017
Q4 		$435K Buy
+659,230
New +$333K 0.45% 47

Kassirer Asset Management's RPRX Position: Q1 2018 in Review

Kassirer Asset Management sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 659,230 shares — an estimated $435K sold.

Kassirer Asset Management first reported a position in RPRX in Q4 2017 and held it in 1 quarter. The position peaked at $435K in Q4 2017. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Kassirer Asset Management reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Kassirer Asset Management sold 659,230 Repros Therapeutics Inc. shares in Q1 2018, an estimated $435K.
  • Kassirer Asset Management first reported a position in Repros Therapeutics Inc. in Q4 2017 and held it in 1 quarter.
  • Kassirer Asset Management's Repros Therapeutics Inc. position peaked at $435K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Kassirer Asset Management's 13F filing for Q1 2018, filed 8 May 2018.